课题基金 / 基金详情

Computational Approaches for Studying Transcription Elongation Control in Cancer

Computational Approaches for Studying Transcription Elongation Control in Cancer
研究癌症转录延伸控制的计算方法
批准号:
10697319
负责人:
Marta Iwanaszko
金额:
$14.44万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-05 至 2027-08-31

项目摘要

项目成果

Marta Iwanaszko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The goal of this proposal is to provide bioinformatics support to advance research into the misregulation of transcription elongation in oncogenesis. For example, translocation of the mixed lineage leukemia (MLL) gene with a variety of genes expressing regulators of transcription elongation result in acute myeloid or acute lymphoid leukemia. Many of these factors are subunits of the Super Elongation Complex (SEC), which can enhance transcription elongation by two submodules: the positive regulator of transcription factor b (P-TEFb), which signals for the release of paused Pol II, and the RNA processivity factor ELL. A common denominator of these projects is the need for meticulous, biologically relevant computational analysis, which ultimately have several functions: decoding next generation sequencing data into a useful set of findings, combining data from multiple experimental platforms for a multi-dimensional perspective, and integrating machine learning approaches to extract data-specific signatures. These functions serve the goal of helping researchers, beginning with study design, data analysis, and further hypothesis building, to advance our understanding of cancer biology and to help evaluate cancer therapeutics. Dr. Iwanaszko will be responsible for implementing these approaches and providing expertise in both bioinformatics and computational biology to support cancer biologists in extracting more information from their data, speeding up the analysis, and to maintain a high standard of scientific rigor and reproducibility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Computational Approaches for Studying Transcription Elongation Control in Cancer
海外基金